Miriam J Johnson1, J Martin Bland2, Patricia M Davidson3, Phillip J Newton3, Stephen G Oxberry4, Amy P Abernethy5, David C Currow6. 1. Palliative Medicine, Hull York Medical School, University of Hull, Hull, United Kingdom. Electronic address: miriam.johnson@hyms.ac.uk. 2. Department of Health Sciences, University of York, Heslington, York, United Kingdom. 3. Cardiovascular and Chronic Care Centre, University of Technology Sydney, St. Vincent's Hospital Sydney, Sydney, New South Wales, Australia. 4. Palliative Medicine, Kirkwood Hospice, Huddersfield, United Kingdom. 5. Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA; Discipline, Palliative and Supportive Services, Flinders University, Daw Park, South Australia, Australia. 6. Discipline, Palliative and Supportive Services, Flinders University, Daw Park, South Australia, Australia.
Abstract
CONTEXT: Performance status is used to quantify the well-being and functional status of people with illness. Clinicians and researchers from differing fields may not instinctively understand the scales, typically disease specific, used in other disciplines. OBJECTIVES: To provide a preliminary description of the relationship between the Karnofsky Performance Status Scale (KPS) and the New York Heart Association Classification (NYHA) and to stimulate discussion in research and clinical practice. METHODS: Simultaneous KPS and NYHA data (172 observations) from three studies of people with chronic heart failure were pooled. Linear regression was used to predict the mean KPS from NYHA. The strength of association between the scales was investigated using a Kendall's Tau-b correlation coefficient. The agreement between the predicted and observed KPS scores was investigated using weighted kappa with quadratic weights. RESULTS: Linear regression demonstrated a relationship between KPS and NYHA (P < 0.0001; R(2) = 0.3). Predicted KPS from NYHA class rounded to the nearest 10 gave the following values: Class I, predicted KPS 90%; Class II, predicted KPS 80%; Class III, predicted KPS 70%; and Class IV, predicted KPS 60%. A moderate strength of association between KPS and NYHA (Kendall's Tau-b correlation coefficient of -0.49; P < 0.0001) and agreement between observed and predicted KPS (kappa coefficient = 0.52) was shown. CONCLUSION: We suggest that the NYHA discriminates poorly between clinically important performance states in people with advanced disease (NYHA III and IV; KPS <50%). The KPS, used in conjunction, would provide useful additional information in research and clinical practice.
CONTEXT: Performance status is used to quantify the well-being and functional status of people with illness. Clinicians and researchers from differing fields may not instinctively understand the scales, typically disease specific, used in other disciplines. OBJECTIVES: To provide a preliminary description of the relationship between the Karnofsky Performance Status Scale (KPS) and the New York Heart Association Classification (NYHA) and to stimulate discussion in research and clinical practice. METHODS: Simultaneous KPS and NYHA data (172 observations) from three studies of people with chronic heart failure were pooled. Linear regression was used to predict the mean KPS from NYHA. The strength of association between the scales was investigated using a Kendall's Tau-b correlation coefficient. The agreement between the predicted and observed KPS scores was investigated using weighted kappa with quadratic weights. RESULTS: Linear regression demonstrated a relationship between KPS and NYHA (P < 0.0001; R(2) = 0.3). Predicted KPS from NYHA class rounded to the nearest 10 gave the following values: Class I, predicted KPS 90%; Class II, predicted KPS 80%; Class III, predicted KPS 70%; and Class IV, predicted KPS 60%. A moderate strength of association between KPS and NYHA (Kendall's Tau-b correlation coefficient of -0.49; P < 0.0001) and agreement between observed and predicted KPS (kappa coefficient = 0.52) was shown. CONCLUSION: We suggest that the NYHA discriminates poorly between clinically important performance states in people with advanced disease (NYHA III and IV; KPS <50%). The KPS, used in conjunction, would provide useful additional information in research and clinical practice.
Authors: William F Parker; Allen S Anderson; Donald Hedeker; Elbert S Huang; Edward R Garrity; Mark Siegler; Matthew M Churpek Journal: J Am Coll Cardiol Date: 2018-04-24 Impact factor: 24.094
Authors: Kristin Filler; Debra Lyon; Nancy McCain; James Bennett; Juan Luis Fernández-Martínez; Enrique Juan deAndrés-Galiana; R K Elswick; Nada Lukkahatai; Leorey Saligan Journal: Biol Res Nurs Date: 2015-11-18 Impact factor: 2.522